A hemagglutinin-esterase-expressing salmonid alphavirus replicon protects Atlantic salmon (Salmo salar) against infectious salmon anemia (ISA). (Q42284355)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 November 2012

Language	Label	Description	Also known as
English	A hemagglutinin-esterase-expressing salmonid alphavirus replicon protects Atlantic salmon (Salmo salar) against infectious salmon anemia (ISA).	scientific article published on 29 November 2012

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

A hemagglutinin-esterase-expressing salmonid alphavirus replicon protects Atlantic salmon (Salmo salar) against infectious salmon anemia (ISA). (English)

1 reference

Europe PubMed Central

19 October 2017

Atlantic salmon

0 references

5

object named as

Espen Rimstad

1 reference

Europe PubMed Central

19 October 2017

author name string

Astrid Wolf

1

1 reference

Europe PubMed Central

19 October 2017

Kjartan Hodneland

2

1 reference

Europe PubMed Central

19 October 2017

Petter Frost

3

1 reference

Europe PubMed Central

19 October 2017

Stine Braaen

4

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

29 November 2012

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

31

1 reference

Europe PubMed Central

19 October 2017

4

1 reference

Europe PubMed Central

19 October 2017

661-669

1 reference

Europe PubMed Central

19 October 2017

A comparative review on European-farmed finfish RNA viruses and their vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against infectious salmon anemia (ISA) and subsequent ISA virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus vectors and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

RNA replicons - a new approach for influenza virus immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Layered amplification of gene expression with a DNA gene delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus-based expression vectors: strategies and applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus vectors for gene expression and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Recovery of a recombinant salmonid alphavirus fully attenuated and protective for rainbow trout

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Phylogenetic analysis of infectious salmon anaemia virus isolates from Norway, Canada and Scotland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Characterization and applications of a monoclonal antibody against infectious salmon anaemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Characterization of the infectious salmon anemia virus fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Segment 8 encodes a structural protein of infectious salmon anaemia virus (ISAV); the co-linear transcript from Segment 7 probably encodes a non-structural or minor structural protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Cloning and identification of the infectious salmon anaemia virus haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Expression profiles of inflammatory and immune-related genes in Atlantic salmon (Salmo salar L.) at early time post vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Genetic markers of the immune response of Atlantic salmon (Salmo salar) to infectious salmon anemia virus (ISAV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Transcription of reference genes used for quantitative RT-PCR in Atlantic salmon is affected by viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Prevalence of infectious salmon anaemia virus (ISAV) in wild salmonids in western Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Protective effects of a DNA vaccine expressing the infectious salmon anemia virus hemagglutinin-esterase in Atlantic salmon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Semiliki forest virus vector carrying the bovine viral diarrhea virus NS3 (p80) cDNA induced immune responses in mice and expressed BVDV protein in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Formation of infectious pancreatic necrosis virus-like particles following expression of segment A by recombinant semliki forest virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Expression of interferon and interferon--induced genes in Atlantic salmon Salmo salar cell lines SHK-1 and TO following infection with Salmon AlphaVirus SAV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Formulations combining CpG containing oliogonucleotides and poly I:C enhance the magnitude of immune responses and protection against pancreas disease in Atlantic salmon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Antiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Infectious salmon anemia virus is a powerful inducer of key genes of the type I interferon system of Atlantic salmon, but is not inhibited by interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Molecular and functional characterization of two infectious salmon anaemia virus (ISAV) proteins with type I interferon antagonizing activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

DNA and RNA-based vaccines: principles, progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Cancer therapy using a self-replicating RNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Vaccination-induced systemic autoimmunity in farmed Atlantic salmon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Development and preclinical evaluation of an alphavirus replicon vaccine for influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Depletion of CD8 alpha cells from tissues of Atlantic salmon during the early stages of infection with high or low virulent strains of infectious salmon anaemia virus (ISAV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Effect of early infectious salmon anaemia virus (ISAV) infection on expression of MHC pathway genes and type I and II interferon in Atlantic salmon (Salmo salar L.) tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Susceptibility and immune responses following experimental infection of MHC compatible Atlantic salmon (Salmo salar L.) with different infectious salmon anaemia virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell Culture Evaluation of the Semliki Forest Virus Expression System As a Novel Approach for Antigen Delivery and Expression in Fish

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.045

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.11.045

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42284355&oldid=1569204692"